Advancing pathology and cancer research with next-generation sequencing | Illumina Video

preview_player
Показать описание
NGS is setting a new standard in cancer research.
Dr. Platt of MPLN shares her experience, using molecular assays in clinical research, and discusses how MPLN uses NGS to further their oncology and research portfolio. She shares case examples of the molecular usability and analysis options for deep sequencing of tumor samples.
Illumina continues to collaborate with leading laboratories to provide focused, complete solutions, powered by NGS.

Presenter
Dr. Jamie Platt
Vice President, Genomic Solutions
Molecular Pathology Laboratory Network, Inc.

Рекомендации по теме